PBAC thumbs-up for biosimilar preference in prescribing software

Decision is in tune with the government's push to improve uptake

The Pharmaceutical Benefits Advisory Committee (PBAC) has given the thumbs up to the idea of biosimilars being the default option in prescribing software.

# Tags